Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASAD for irinotecan-induced diarrhea in metastatic colorectal cancer
NCT00748215Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2009
- Primary completion
- Aug 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of calcium aluminosilicate in diarrhea, sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2009; status: completed.
02
Drugs
calcium aluminosilicate
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT00748215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00748215.